Kenneth Cundy
Direttore Tecnico/Scientifico/R&S presso ANEBULO PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Kenneth Cundy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 20/05/2022 | - |
Storia della carriera di Kenneth Cundy
Precedenti posizioni note di Kenneth Cundy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| COHBAR, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2014 | 31/03/2022 |
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2000 | 01/11/2014 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/1992 | 01/01/2000 |
Formazione di Kenneth Cundy
| The University of Manchester | Undergraduate Degree |
| University of Kentucky | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Israele | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| COHBAR, INC. | Health Technology |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Borsa valori
- Insiders
- Kenneth Cundy
- Esperienza
